Differentiated activities now define the value of CRO contributions, transforming a transactional-based relationship to a strategic one. Published in Pharma Tech Outlook, May 2017, by Michael Murphy, M.D., Ph.D.
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
